Not meant for U.S. and UK Media
Berlin, October 20,2022— Bayer revealed today that it has actually gotten a grant from the Bill & & Melinda Gates Foundation. As part of the grant, Bayer and the Bill & & Melinda Gates Foundation have actually each devoted more than US$ 12 million over 4 years to co-fund pre-clinical research study activities with the objective of offering ladies internationally with an alternative for non-hormonal birth control. In addition to research study co-funding over a four-year duration, Bayer will utilize its experience in females’s health care in addition to research study and advancement proficiency in order to determine a pre-clinical advancement prospect. Bayer has actually likewise dedicated to make such an item readily available in low- and lower-middle-income nations at a cost effective rate once it would have been authorized by health authorities.
” The cooperation combines Bayer’s research study competence, with the Bill & & Melinda Gates Foundation’s function, to lower inequalities around the globe by assisting in access to health in low- and lower-middle-income nations,” stated Marianne De Backer, Executive Vice President, Head of Strategy, Business Development & & Licensing/Open Innovation and Member of the Executive Committee of Bayer’s Pharmaceutical Division. “Together, we intend to more advance our vision to offer extremely wanted ingenious non-hormonal contraceptive alternatives to countless ladies and ladies around the world in a sustainable way.”
” Sustainability is an important part of our company,” stated Jeanne Kehren, Senior Vice President Digital & & Commercial Innovation, Chief Information Officer, along with accountable for Sustainability and a Member of the Executive Committee of Bayer’s Pharmaceutical Division. “With our strong heritage and deeply rooted knowledge in ladies’s health care, Bayer has actually been supporting efforts that add to supplying women and ladies in low- and lower-middle-income nations with access to household preparation for more than 50 years. We are happy to collaborate with the Bill & & Melinda Gates Foundation and sign up with efforts to broaden access to contraceptive alternatives that resolve the unmet requirements of females worldwide.”
This brand-new collaboration contributes to Bayer’s dedication focusing o